Skip to Main Content

INFORMATION FOR

Lieping Chen, MD, PhD

United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology)

Appointments

Biography

Dr. Lieping Chen is an immunologist interested in basic T cell biology, cancer immunology, and translational research to develop new treatments for human diseases including cancer. Prior to joining Yale, he was a faculty member at Johns Hopkins University School of Medicine and Mayo Clinic, and a scientist in Bristol-Myers Squibb Pharmaceutical Research Institute.

Dr. Chen has published over 370 peer-reviewed research articles. His work in the discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the year by Science magazine in 2013. He is a member of the National Academy of Sciences and a fellow of the American Association for Cancer Research and the Society for Immunotherapy of Cancer.

Education & Training

  • PhD
    Drexel University, Pathology and Laboratory Medicine (1989)
  • MS
    Beijing Union Medical College, Immunology (1986)
  • MD
    Fujian Medical College (1982)

Honors & Recognition

AwardAwarding OrganizationDate
Richard V. Smalley MD Memorial AwardSociety for Immunotherapy of Cancer2020
AcademicianAcademia Sinica2018
Warren Alpert Foundation PrizeWarren Alpert Foundation2017
AAI-Steinman AwardAmerican Association of Immunologists2016
William B. Coley AwardCancer Research Institute2014

Departments & Organizations